National Health Investors (NHI) is back in front of institutional investors as the real estate investment trust presents at the BofA NY Global Real Estate Conference 2026 in New York on September 15.
Recent trading paints a mixed picture for National Health Investors. The share price has slipped about 8% over the past month and 13% over 90 days, while the 1-year total shareholder return is down 11.7%. However, 3-year and 5-year total shareholder returns of 51.24% and 64.61% indicate that long-term holders have still seen meaningful gains despite the recent loss of momentum.
Scan how National Health Investors compares with other real estate income plays by reviewing our hand picked 7 dividend fortresses in one place.
National Health Investors has delivered solid multi year returns, even as the share price has pulled back in recent months. The real question now is whether that established real estate platform is on sale or already fairly valued.
Most Popular Narrative: 18% Undervalued
The most followed valuation narrative pegs National Health Investors at a fair value of $82.13, which sits above the recent $67.16 close and frames the current pullback as a potential disconnect between price and underlying assumptions.
NHI's focused expansion of its SHOP (Senior Housing Operating Portfolio) segment with double-digit NOI growth projected and a robust pipeline of accretive acquisitions positions the company for outsized multi-year NOI and earnings growth relative to peers.
See why 17 investors see National Health Investors as 18% undervalued.
Result: Fair Value of $82.13 (UNDERVALUED)
Still, that undervaluation story can unravel quickly if occupancy softness in the SHOP portfolio lingers or if key tenants struggle and put pressure on rental income.
Find out about the key risks to this National Health Investors narrative.
Next Steps
Mixed sentiment around National Health Investors is clear, so consider acting promptly and testing the thesis yourself by weighing the 3 key rewards and 4 important warning signs.
Looking for more ideas beyond National Health Investors?
If you only focus on National Health Investors, you could overlook income, quality and value opportunities that fit your goals just as well or even better.
- Target reliable income streams by scanning a curated set of high yield opportunities through our 7 dividend fortresses.
- Hunt for quality at a discount by checking companies filtered as potential value candidates in the 30 high quality undervalued stocks.
- Prioritise resilience by assessing financially robust businesses via the list of solid balance sheet and fundamentals (24 results).
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com